{
    "nct_id": "NCT03173924",
    "official_title": "Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n* Age greater than or equal to 18 years old\n* Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2.\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n* Patients must have confirmation of prostate cancer with identifiable metastatic disease on at least 1 clinically indicated imaging modality. If there is only soft tissue metastasis, one lesion must measure at least 6 mm or greater. OR Documented history of metastatic prostate cancer.\n* Patients must be co-enrolled on a UOB, GMB or ROB protocol\n* Histological confirmation of prostate cancer\n* Patients must be willing to undergo mandatory research biopsy\n\nEXCLUSION CRITERIA:\n\n* Subjects for whom participating would significantly delay the scheduled standard of care therapy.\n* Subjects with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results.\n* Subjects with severe claustrophobia unresponsive to oral anxiolytics\n* Other medical conditions deemed by the principal investigator (or associates) to make the subject unsafe/ineligible for protocol procedures.\n* Subjects weighing greater than 350 lbs. (weight limit for scanner table), or unable to fit within the imaging gantry\n* Serum creatinine greater than 2 times the upper limit of normal\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}